Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 2020

View Archived Issues

Autophagy linked to neurotransmission

A promising multitarget antipsychotic among piperidine-amide substituted derivatives

Immuron reports new data on vaccine targeting Campylobacter and ETEC

Arcturus reports interim data from phase I/II study of COVID-19 vaccine candidate ARCT-021

Gilead Sciences patents HIV protease inhibitors

Aligos Therapeutics divulges new compounds for hepatitis

Vivace Therapeutics synthesizes YAP1/TEAD interaction inhibitors

LIfT BioSciences reports in vivo data on N-LIfT for pancreatic cancer

GBiotech Sarl presents new FFAR1 agonists

Chinese researchers discover EpCAM-targeting antibodies

hAd5-COVID-19 stimulates memory T-cell recall in previously infected COVID-19 patients

First patient dosed in phase I study of NTLA-2001 in hATTR-PN

Researchers develop a new Ptpn14-knockout murine model of HHT

European Commission approves Calquence for the treatment of CLL

Study shows how mutant KRAS initiates pancreatic cancer

Preclinical characterization of [99mTc]Tc-TECANT-1

[125I]PIB-Ec1 as promising tracer for imaging EpCAM expression in ovarian cancer

Phase III NAVIGATOR study of tezepelumab in severe asthma meets primary endpoint

GlaxoSmithKline's RSVPreF3 candidate vaccine shows promising clinical results

Arena reports topline phase IIb results with etrasimod in atopic dermatitis

New phase Ib/IIa trial examines Immunophotonics' IP-001 in thermally ablated solid tumors

FDA issues EUA for Lilly's bamlanivimab to treat recently diagnosed COVID-19

Phase I/II data with PKU gene therapy HMI-102 show marked reductions in Phe at two doses

Phase III CARDINAL study of bardoxolone in Alport syndrome meets primary endpoint

FDA approves Totect to treat cardiomyopathy in women receiving doxorubicin for breast cancer

Sorrento files IND for STI-2020 for treatment of COVID-19

FDA issues complete response letter for SPN-812 for ADHD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...